Coastline Trust Co grew its holdings in shares of Davita Inc (NYSE:DVA) by 6.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 16,120 shares of the company’s stock after buying an additional 950 shares during the quarter. Coastline Trust Co’s holdings in Davita were worth $1,165,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in DVA. Schroder Investment Management Group raised its position in shares of Davita by 769.0% during the 3rd quarter. Schroder Investment Management Group now owns 434,191 shares of the company’s stock valued at $25,387,000 after buying an additional 384,224 shares in the last quarter. Canada Pension Plan Investment Board raised its position in shares of Davita by 14.7% during the 3rd quarter. Canada Pension Plan Investment Board now owns 444,358 shares of the company’s stock valued at $26,390,000 after buying an additional 56,988 shares in the last quarter. Speece Thorson Capital Group Inc. raised its position in shares of Davita by 14.5% during the 3rd quarter. Speece Thorson Capital Group Inc. now owns 321,182 shares of the company’s stock valued at $19,075,000 after buying an additional 40,667 shares in the last quarter. Meag Munich Ergo Kapitalanlagegesellschaft MBH raised its position in shares of Davita by 1,987.3% during the 3rd quarter. Meag Munich Ergo Kapitalanlagegesellschaft MBH now owns 41,746 shares of the company’s stock valued at $2,448,000 after buying an additional 39,746 shares in the last quarter. Finally, Oak Associates Ltd. OH raised its position in shares of Davita by 21.1% during the 2nd quarter. Oak Associates Ltd. OH now owns 185,195 shares of the company’s stock valued at $11,993,000 after buying an additional 32,285 shares in the last quarter. Hedge funds and other institutional investors own 87.97% of the company’s stock.

Shares of Davita Inc (NYSE:DVA) opened at $79.06 on Thursday. The company has a debt-to-equity ratio of 1.79, a current ratio of 1.40 and a quick ratio of 1.35. Davita Inc has a 1 year low of $52.51 and a 1 year high of $80.71. The firm has a market cap of $14,508.20, a PE ratio of 30.41 and a beta of 0.96.

Davita (NYSE:DVA) last posted its quarterly earnings data on Tuesday, November 7th. The company reported $0.81 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.94 by ($0.13). Davita had a return on equity of 13.31% and a net margin of 3.40%. The firm had revenue of $3.92 billion during the quarter, compared to analysts’ expectations of $3.91 billion. During the same period last year, the company earned $0.95 earnings per share. The business’s revenue for the quarter was up 5.2% compared to the same quarter last year. equities research analysts predict that Davita Inc will post 3.42 earnings per share for the current fiscal year.

Davita declared that its Board of Directors has approved a share buyback program on Tuesday, October 10th that authorizes the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s board of directors believes its shares are undervalued.

Several analysts have recently issued reports on DVA shares. TheStreet upgraded shares of Davita from a “c” rating to a “b-” rating in a research report on Thursday, January 4th. Citigroup upgraded shares of Davita from a “neutral” rating to a “buy” rating and upped their target price for the company from $67.71 to $82.00 in a research report on Monday, December 11th. Bank of America upgraded shares of Davita from a “neutral” rating to a “buy” rating and upped their target price for the company from $75.00 to $85.00 in a research report on Thursday, January 4th. Robert W. Baird restated a “buy” rating and set a $95.00 target price (up from $82.00) on shares of Davita in a research report on Friday, January 12th. Finally, SunTrust Banks set a $70.00 price objective on shares of Davita and gave the stock a “hold” rating in a research report on Thursday, December 7th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating, four have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $78.22.

In other Davita news, VP Leanne M. Zumwalt sold 949 shares of the company’s stock in a transaction dated Friday, December 8th. The shares were sold at an average price of $68.19, for a total value of $64,712.31. Following the transaction, the vice president now directly owns 12,423 shares in the company, valued at approximately $847,124.37. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Chairman Kent J. Thiry sold 81,800 shares of the company’s stock in a transaction dated Friday, December 8th. The stock was sold at an average price of $68.04, for a total transaction of $5,565,672.00. The disclosure for this sale can be found here. Insiders sold a total of 117,937 shares of company stock worth $8,028,379 over the last three months. 2.10% of the stock is currently owned by corporate insiders.

ILLEGAL ACTIVITY NOTICE: “Coastline Trust Co Acquires 950 Shares of Davita Inc (DVA)” was published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark law. The correct version of this news story can be viewed at https://theolympiareport.com/2018/01/18/coastline-trust-co-acquires-950-shares-of-davita-inc-dva.html.

Davita Profile

DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).

Institutional Ownership by Quarter for Davita (NYSE:DVA)

Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.